Continuous Improvement Versus Innovation: The Case for Sipuleucel-T

被引：3
|
作者：
Tombal, Bertrand [1 ]
机构：
[1] Catholic Univ Louvain, Serv Urol, Clin Univ St Luc, B-1200 Brussels, Belgium
来源：
EUROPEAN UROLOGY | 2012年 / 61卷 / 04期
关键词：
PROSTATE-CANCER; MITOXANTRONE; PREDNISONE; DOCETAXEL;
D O I：
10.1016/j.eururo.2011.11.033
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：648 / 649
页数：2
相关论文
共 50 条
  • [41] Targeted treatment of metastatic castration-resistant prostate cancer with sipuleucel-T immunotherapy
    Mulders, Peter F.
    De Santis, Maria
    Powles, Thomas
    Fizazi, Karim
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2015, 64 (06) : 655 - 663
  • [42] Moving on From Sipuleucel-T: New Dendritic Cell Vaccine Strategies for Prostate Cancer
    Sutherland, Sarah I. M.
    Ju, Xinsheng
    Horvath, L. G.
    Clark, Georgina J.
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [43] Sipuleucel-T: APC 8015, APC-8015, prostate cancer vaccine - Dendreon
    不详
    Drugs in R & D, 2006, 7 (3) : 197 - 201
  • [44] Real-World Effectiveness of Sipuleucel-T on Overall Survival in Men with Advanced Prostate Cancer Treated with Androgen Receptor-Targeting Agents
    Hafron, Jason M.
    Wilfehrt, Helen M.
    Ferro, Christine
    Harmon, Matt
    Flanders, Scott C.
    McKay, Rana R.
    ADVANCES IN THERAPY, 2022, 39 (06) : 2515 - 2532
  • [45] Quality of Life After Sipuleucel-T Therapy: Results From a Randomized, Double-blind Study in Patients With Androgen-dependent Prostate Cancer
    Beer, Tomasz M.
    Schellhammer, Paul F.
    Corman, John M.
    Glode, L. Michael
    Hall, Simon J.
    Whitmore, James B.
    Frohlich, Mark W.
    Penson, David F.
    UROLOGY, 2013, 82 (02) : 410 - 415
  • [46] PROVENGE (Sipuleucel-T) in Prostate Cancer: The First FDA-Approved Therapeutic Cancer Vaccine
    Cheever, Martin A.
    Higano, Celestia S.
    CLINICAL CANCER RESEARCH, 2011, 17 (11) : 3520 - 3526
  • [47] Sipuleucel-T in the treatment of prostate cancer: an evidence-based review of its place in therapy
    Graff, Julie N.
    Chamberlain, Erin D.
    CORE EVIDENCE, 2015, 10 : 1 - 10
  • [48] Sipuleucel-T and Androgen Receptor-Directed Therapy for Castration-Resistant Prostate Cancer: A Meta-Analysis
    Yi, Renliang
    Chen, Baoxin
    Duan, Peng
    Zheng, Chanjiao
    Shen, Huanyu
    Liu, Qun
    Yuan, Chen
    Ou, Weilin
    Zhou, Zhiheng
    JOURNAL OF IMMUNOLOGY RESEARCH, 2016, 2016
  • [49] The Role of Sipuleucel-T in Therapy for Castration-Resistant Prostate Cancer: A Critical Analysis of the Literature
    Sonpavde, Guru
    Di Lorenzo, Giuseppe
    Higano, Celestia S.
    Kantoff, Philip W.
    Madan, Ravi
    Shore, Neal D.
    EUROPEAN UROLOGY, 2012, 61 (04) : 639 - 647
  • [50] A Transient Increase in Eosinophils Is Associated with Prolonged Survival in Men with Metastatic Castration-Resistant Prostate Cancer Who Receive Sipuleucel-T
    McNeel, Douglas G.
    Gardner, Thomas A.
    Higano, Celestia S.
    Kantoff, Philip W.
    Small, Eric J.
    Wener, Mark H.
    Sims, Robert B.
    DeVries, Todd
    Sheikh, Nadeem A.
    Dreicer, Robert
    CANCER IMMUNOLOGY RESEARCH, 2014, 2 (10) : 988 - 999
12345